Mary Chapman, features writer —

A recent survey about medical cannabis use by Parkinson’s disease (PD) patients in the U.S. found one-quarter of its more than 1,000 respondents had used cannabis in the last six months, and less than 13% reported negative side effects. Most of these people reported using cannabis to treat nonmotor Parkinson’s symptoms…

To encourage more diversity in Parkinson’s investigations and better capture how the disorder affects patients across racial, socioeconomic, and other lines, The Michael J. Fox Foundation (MJFF) has opened an international program to fund projects that promote greater inclusion in Parkinson’s research. Awarded projects could receive from $50,000 up to…

A free virtual symposium about U.S. veterans, their families, and Parkinson’s disease (PD) is on tap for Saturday, March 20. Called “Veterans and Parkinson’s Disease: What You Need to Know,” the three-hour Zoom event runs opens at 9 a.m. EST, and is presented by the Parkinson’s Foundation and the…

A $670,000 grant by the Michael J. Fox Foundation will go toward advancing a technology platform that might lead to a smell test to detect Parkinson’s disease (PD) in its early stages, allowing an earlier start to treatment and, possibly, leading to better therapies. The grant, given to…

With north of 150,000 followers on his TikTok account, elite athlete Jimmy Choi knows his way around social media. After all, the ultra marathoner has competed on four seasons of the popular TV series “American Ninja Warrior.” He’s also had Parkinson’s disease (PD) since 2003. Still, nothing prepared…

Pharmather has filed a request to meet with the U.S. Food and Drug Administration (FDA) to determine next best steps in the clinical development of ketamine to treat the levodopa-induced dyskinesia associated with Parkinson’s disease. The filing is in preparation for a proposed Phase 2 clinical study of ketamine,…

A multiyear McCamish Foundation funding commitment is expected to enhance the scope and reach of Parkinson’s disease research at Georgia Institute of Technology and Emory University. It also could help make the state of Georgia a hub for collaborative research on neurological diseases. The McCamish pledge — an unspecified amount…

MapLight Therapeutics will use an $8.1 million three-year grant to tackle the common symptoms of anxiety and depression in Parkinson’s disease. The Michael J. Fox Foundation for Parkinson’s Research (MJFF) grant will enable the biopharmaceutical company to open an expansive, systematic exploration of brain circuits and…

An upgrade to the American Parkinson Disease Association (APDA) Symptom Tracker App, available to patients and caregivers at no cost, includes improvements to make for an easier and more detailed user experience and a Spanish language version. The mobile app, first released last year, was developed to help people…

Of the roughly 1 million U.S. residents with Parkinson’s disease, some 110,000 are veterans. To improve this population’s health, well-being, and quality of life, the U.S. Department of Veterans Affairs (VA) has formed a partnership with the Parkinson’s Foundation. The intent of the collaboration is to…